As genome editing therapies move through clinical trials to regulatory approval, scientists continue the quest for the holy ...

Unlike traditional proteins, its short structure allows it to act as an epigenetic modulator, potentially influencing gene ...

This article explores how advances in AI, structural biology, and new drug modalities are transforming “undruggable” proteins ...

A new review finds that next-generation BET-targeted therapies, including selective inhibitors and PROTACs, are addressing ...

RNA has emerged as one of the most promising molecules in modern medicine, enabling advances from mRNA vaccines and gene ...

The expanding interest in small bioactive peptides has brought renewed attention to glycyl-L-histidyl-L-lysine bound to ...

A new study reveals experimental drug XL20 crosses the blood-brain barrier to stop toxic TDP-43 clumping in ALS.

Lund University. An international research team led by Lund University and the University of New South Wales has created an ...

Severance Hospital announced that a research team led by Prof. Kim Hyung-pyo of the Department of Tropical Medicine at Yonsei ...

Frances Arnold on directed enzyme evolution: random mutation plus smart screening, and why it changed enzyme engineering and ...